paxilline has been researched along with bay-k-8644 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Matsumoto, K; Miyamotq, T; Oka, H; Osajima, K; Tanaka, M; Toshiro, M; Ueno, T | 1 |
| Carabelli, V; Carbone, E; Mahapatra, S; Marcantoni, A; Sinnegger-Brauns, MJ; Striessnig, J; Vandael, DH | 1 |
3 other study(ies) available for paxilline and bay-k-8644
| Article | Year |
|---|---|
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Division; Cells, Cultured; Cytoskeletal Proteins; Dipeptides; Humans; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Potassium Channel Blockers; Vasoconstrictor Agents | 2005 |
Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Cortex; Adrenal Medulla; Animals; Biophysical Phenomena; Biophysics; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chelating Agents; Chromaffin Cells; Dose-Response Relationship, Drug; Egtazic Acid; Electric Stimulation; Gene Expression Regulation; Indoles; Ionophores; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Mice; Mice, Knockout; Patch-Clamp Techniques; Potassium Channel Blockers; Spider Venoms; Time Factors | 2010 |